Receptor interaction profiles of 4-alkoxy-2,6-dimethoxyphenethylamines (Ψ derivatives) and related amphetamines

The Ψ derivatives mainly interacted with the 5-HT<sub>2A</sub> receptor, the primary target for psychedelics, as well as with the 5-HT<sub>2C</sub> receptor. The same 4-alkyloxy modification pattern on the related 2,4,5-trisubstituted derivatives exhibited generally slightly more potent 5-HT<sub>2A</sub> receptor binding and activation, whereas 3,4,5-trisubstituted derivatives interacted with lower potency; in humans, 2,4,6-trisubstituted derivatives may thus be less potent compared to their 2,4,5-trisubsititued counterparts but more potent compared to their 3,4,5-trisubsititued counterparts.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-11-20
DOI
https://doi.org/10.3389/fphar.2025.1703480
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Receptor interaction profiles of 4-alkoxy-2,6-dimethoxyphenethylamines (Ψ derivatives) and related amphetamines

Dino Luethi, Marius C. Hoener, Karolina E. Kolaczynska, Matthias E. Liechti et al.
Frontiers in Pharmacology
Psychedelics and Drug Studies
article

Receptor interaction profiles of 4-alkoxy-2,6-dimethoxyphenethylamines (Ψ derivatives) and related amphetamines

Dino Luethi, Marius C. Hoener, Karolina E. Kolaczynska, Matthias E. Liechti, Daniel Trachsel
article en

Abstract

The Ψ derivatives mainly interacted with the 5-HT<sub>2A</sub> receptor, the primary target for psychedelics, as well as with the 5-HT<sub>2C</sub> receptor. The same 4-alkyloxy modification pattern on the related 2,4,5-trisubstituted derivatives exhibited generally slightly more potent 5-HT<sub>2A</sub> receptor binding and activation, whereas 3,4,5-trisubstituted derivatives interacted with lower potency; in humans, 2,4,6-trisubstituted derivatives may thus be less potent compared to their 2,4,5-trisubsititued counterparts but more potent compared to their 3,4,5-trisubsititued counterparts.

Frontiers in PharmacologyVol. 16
Roche (Switzerland) (CH), University of Basel (CH), University Hospital of Basel (CH), Universitätsklinik für Diabetologie, Endokrinologie, Ernährungsmedizin & Metabolismus (CH)
National Science Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Bundesamt für Gesundheit
Openalex Percentile: Top 53%
Psychedelics and Drug Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Receptor interaction profiles of 4-alkoxy-2,6-dimethoxyphenethylamines (Ψ derivatives) and related amphetamines — Dino Luethi, Marius C. Hoener, et al. · Frontiers in Pharmacology (2025) | TGRS Research Map | TGRS